Ebola: experimental drug cures monkeys infected with the virus
Scientists developing TKM-Ebola celebrate successful animal trial as the race for a human cure continues

Scientists have used an experimental drug to successfully treat monkeys with Ebola, raising hopes of a human cure.
"This is the first study to show post-exposure protection," senior author Thomas Geisbert told the BBC.
TKM-Ebola-Guinea targets the Makona strain of the virus which is responsible for the ongoing outbreak in West Africa that has left over 10,000 people dead.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Developed by a Canadian pharmaceutical company, the drug works by interfering with the virus's genetic code, stopping it from producing disease-causing proteins.
One of the main advantages of the drug is that it can be easily modified to target different strains of virus. It is also be relatively quickly manufactured, while alternative drugs – such as the experimental ZMapp – take several months to produce.
During the animal trial, six monkeys were given a lethal dose of the virus. Three days later, half were given the drug while the other half were left untreated. All of the animals who received TKM Ebola went on to make a full recovery, while the others three died within nine days.
Geisbert said his team were hopeful that the results could be replicated in humans. "In most cases we would say there is a 90 per cent chance that this would work but not 100 per cent – there's nothing that is that definitive," he told the Daily Telegraph.
A number of Ebola patients received the experimental drug during the outbreak, but as they were given several other treatments it is impossible to identify which one was responsible for their recovery.
A large-scale human trial of the drug has already begun in Sierra Leone, but its safety and efficacy are still unknown, with results only expected to be released later this year.
The Ebola outbreak in West Africa is waning, but the World Health Organization continues to warn against complacency, and the race to develop a cure is ongoing.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - April 20, 2025
Cartoons Sunday's cartoons - Pam Bondi, retirement planning, and more
By The Week US
-
5 heavy-handed cartoons about ICE and deportation
Cartoons Artists take on international students, the Supreme Court, and more
By The Week US
-
Exploring the three great gardens of Japan
The Week Recommends Beautiful gardens are 'the stuff of Japanese landscape legends'
By The Week UK
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
By Rafi Schwartz, The Week US
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK